Ecri Bv
Clinical trials sponsored by Ecri Bv, explained in plain language.
-
New drug aims to calm heart arteries after attack
Disease control Not yet recruitingThis study is testing whether a new drug called ziltivekimab can help stabilize the fatty plaques in heart arteries after a heart attack. About 332 participants who recently had a heart attack will be randomly assigned to receive either the new drug or a placebo injection once a …
Phase: PHASE3 • Sponsor: ECRI bv • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC
-
Heart study aims to close care gaps for minority patients
Knowledge-focused Not yet recruitingThis study aims to gather information on how well a specific ultrasound-guided procedure works for treating complex heart blockages in patients from minority groups. It will follow about 1,010 patients for up to two years after their procedure to track their health outcomes. The …
Sponsor: ECRI bv • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC